Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Emergencias ; 35(3): 205-217, 2023 Jun.
Artigo em Espanhol, Inglês | MEDLINE | ID: mdl-37350603

RESUMO

OBJECTIVES: To draft a list of actions and quality indicators for pharmacist care in hospital emergency departments, based on consensus among a panel of experts regarding which actions to prioritize in this setting. MATERIAL AND METHODS: A panel of experts from the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Emergency Medicine (SEMES) evaluated a preliminary list of potential actions and quality of care indicators. The experts used a questionnaire to assess the proposals on the basis of available evidence. In the first round, each expert individually assessed the importance of each proposed action based on 4 dimensions: evidence base, impact on clinical response and patient safety, ease of implementation, and priority. In the second round the experts attended a virtual meeting to reach consensus on a revised list of proposals; suggestions and comments that had been made anonymously in the first round were included. The group then prioritized each action as basic, intermediate, or advanced. RESULTS: The experts evaluated a total of 26 potential actions and associated quality indicators. No items were eliminated in the analysis of scores and comments from the first round. After the second round, 25 actions survived. Nine were considered basic, 10 intermediate, and 6 advanced. CONCLUSION: The expert panel's list of pharmacist actions and care quality indicators provides a basis for developing a pharmacist care program in Spanish emergency departments on 3 levels of priority. The list can serve as a guide to pharmacists, managers, physicians, and nurses involved in the effort to improve drug therapy in this hospital setting.


OBJETIVO: Desarrollar un conjunto de actividades e indicadores de atención farmacéutica en los servicios de urgencias hospitalarios mediante un consenso colectivo de un panel de expertos que permita priorizar las actividades a realizar por los farmacéuticos en estas unidades. METODO: Un comité formado por miembros de la Sociedad Española de Farmacia Hospitalaria (SEFH) y de la Sociedad Española de Medicina de Urgencias y Emergencias (SEMES) evaluó una propuesta inicial de actividades e indicadores potenciales, basados en la evidencia científica disponible, en formato de cuestionario. En una primera ronda, cada uno de los expertos del panel clasificó de forma individual la relevancia de cada una de las actividades propuestas en cuatro dimensiones: evidencia científica, impacto en la respuesta clínica y seguridad para el paciente, facilidad de implementación y grado de prioridad. La segunda ronda se realizó mediante una reunión grupal de forma virtual, a partir del cuestionario modificado de acuerdo con las sugerencias planteadas, así como los comentarios vertidos por los participantes del panel de forma anónima. En esta ronda, cada actividad fue clasificada por consenso como básica, intermedia o avanzada en función del grado de prioridad de implantación considerado por el grupo de expertos. RESULTADOS: Se propusieron un total de 26 potenciales actividades a los expertos, con indicadores asociados. Tras el análisis de las puntuaciones y los comentarios realizados en la primera ronda, no se eliminó ninguna de las actividades propuestas. Tras la segunda ronda, se mantuvieron 25 actividades, de las cuales se puntuaron 9 como actividades básicas, 10 actividades como intermedias y 6 actividades como avanzadas. CONCLUSIONES: El desarrollo del conjunto de actividades e indicadores de atención farmacéutica en urgencias, priorizados por grado de relevancia para la unidad, es la base para el desarrollo de esta cartera de servicios en los hospitales españoles, y sirve como guía tanto para farmacéuticos como para gestores, médicos y enfermeros de la unidad a fin de mejorar la farmacoterapia los pacientes atendidos en los servicios de urgencias.


Assuntos
Medicina de Emergência , Serviço de Farmácia Hospitalar , Humanos , Farmacêuticos , Consenso , Serviço Hospitalar de Emergência , Hospitais
2.
Stud Health Technol Inform ; 166: 189-96, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21685624

RESUMO

The comparison of the patient's current medication list with the medication being ordered when admitted to Hospital, identifying omissions, duplications, dosing errors, and potential interactions, constitutes the core process of medicines reconciliation. Access to the medication the patient is taking at home could be unfeasible as this information is frequently stored in various locations and in diverse proprietary formats. The lack of interoperability between those information systems, namely the Primary Care and the Specialized Electronic Health Records (EHRs), facilitates medication errors and endangers patient safety. Thus, the development of a Patient Summary that includes clinical data from different electronic systems will allow doctors access to relevant information enabling a safer and more efficient assistance. Such a collection of data from heterogeneous and distributed systems has been achieved in this Project through the construction of a federated view based on the ISO/CEN EN13606 Standard for architecture and communication of EHRs.


Assuntos
Continuidade da Assistência ao Paciente/organização & administração , Administração Hospitalar , Sistemas Computadorizados de Registros Médicos/organização & administração , Admissão do Paciente , Protocolos Clínicos , Humanos , Sistemas de Informação/organização & administração
3.
Stud Health Technol Inform ; 148: 123-30, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19745242

RESUMO

A concept-based terminology that covers all features of healthcare is essential for the development of an Electronic Health Record (EHR). Since a significant percentage of the EHR can be drug related information, we decided to implement the controlled drug terminology provided by SNOMED CT to achieve the potential benefit to promote Patient Safety that a fully functional pharmacy system can offer. One of the expected advantages of our Project is to establish a bridge between reference terminology and the drug knowledge databases. There is also an economic advantage of implementing a "clinical drug product", the one defined by the drug name, its strength and dose form, instead of the manufactured drug product. The Pharmacy economic management of stocks and response to the offers from the pharmaceutical companies is another expected asset of the Project. This Project is intended as well to give support to a more widespread objective of interoperability with the Primary Care systems.


Assuntos
Bases de Dados como Assunto , Hospitais Gerais , Preparações Farmacêuticas , Systematized Nomenclature of Medicine , Sistemas de Informação Hospitalar , Semântica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA